| 
			
			 What’s more, only about one in eight is aware that some of the 
			cancers can be linked to human papillomavirus, or HPV. The sexually 
			transmitted infection is better known for causing cervical cancer in 
			women, but is also behind an increase in the rate of throat cancer, 
			particularly among men. 
 “Public awareness of head and neck cancer is really, really low, and 
			that is probably harming people because they’re not aware of the 
			risk factors and symptoms,” senior author Dr. Benjamin Judson, from 
			the Yale University School of Medicine in New Haven, Connecticut 
			told Reuters Health.
 
 Head and neck cancers include cancer of the throat, voice box, mouth 
			and tongue. Smoking causes more than 75 percent of the cases in the 
			United States, the authors write in JAMA Otolaryngology–Head and 
			Neck Surgery.
 
 The cancers have been declining overall, the researchers note. But 
			studies show that rates of throat cancer tied to HPV, which can be 
			transmitted through oral sex, tripled between 1988 and 2004.
 
			
			 
			“It’s an epidemic,” Judson said.
 Head and neck cancers account for about three percent of all cancers 
			in U.S. adults.
 
 Head and neck cancer patients, including actor Michael Douglas, who 
			was diagnosed in 2010 with late-stage throat cancer that he 
			attributed to oral sex, tend to seek care after the disease has 
			progressed to advanced stages. In those cases, treatment is more 
			challenging and survival less likely.
 
 “Head and neck cancer is about as common as thyroid cancer and 
			melanoma, but it causes more deaths than the two cancers combined,” 
			Judson said. “If people are aware of the risks and the signs and 
			symptoms, they could be diagnosed earlier.”
 
 He and his colleagues surveyed 2,126 adults to gauge their knowledge 
			of head and neck cancers. The vast majority who completed an online 
			questionnaire knew little or nothing about the tumors or their 
			causes and symptoms, the study found.
 
 Less than one percent of respondents identified HPV as a risk factor 
			for mouth and throat cancer, though in specific questions about 13 
			percent said they knew of an association between HPV and throat 
			cancer.
 
 Respondents with a college degree were more likely to associate HPV 
			infection with throat cancer; still, less than 15 percent made the 
			connection.
 
 Less than 15 percent of respondents recognized sores that never heal 
			as a symptom of the diseases. Only five percent recognized a sore 
			throat as a symptom and just half a percent saw mouth or throat 
			bleeding as a sign of cancer.
 
 The most common symptoms of throat cancer are voice changes, 
			difficulty swallowing, mouth lesions that don’t heal, neck lumps and 
			mouth sores, speech pathologist Edie Hapner told Reuters Health.
 
            [to top of second column] | 
 
			Hapner, from Emory University in Atlanta, was not involved in the 
			current research but has studied public awareness of head and neck 
			cancers.
 The lack of public knowledge about the diseases came as no surprise 
			to Hapner.
 
 “The biggest problem is not just the lack of knowledge by the public 
			but by a lot of the medical community,” she said.
 
 In a not-yet-published study, Hapner questioned medical students who 
			had already received training in head and neck cancers and found 
			they felt insufficiently prepared to perform screening exams for 
			head and neck tumors. An hour and a half of training significantly 
			improved the medical students’ confidence and ability, she said.
 
 In a 2013 recommendation, the government-backed U.S. Preventive 
			Services Task Force said there is not enough evidence to determine 
			whether screening people without symptoms for oral cancer has any 
			net benefit.
 
 The annual number of HPV-positive throat cancers is expected to 
			surpass the annual number of cervical cancers by the year 2020, 
			according to a 2011 study in the Journal of Clinical Oncology.
 
 Researchers in 2012 estimated that nearly seven percent of Americans 
			ages 14 to 69 had oral HPV infections. Moreover, HPV rates were as 
			high as 20 percent among people who had more than 20 lifetime sex 
			partners or smoked more than a pack of cigarettes per day.
 
 Two vaccines that reduce the risk of HPV infection and were designed 
			to prevent cervical cancer are available for children and young 
			adults. But researchers do not know if they prevent oral HPV 
			infections, and federal regulators have not approved either vaccine 
			for the prevention of head and neck cancer.
 
			
			 
			“Unfortunately, we’re going to see more and more people with head 
			and neck cancer,” Judson said. “There’s a need for more public 
			education to raise awareness.”
 SOURCE: http://bit.ly/1p2B0GJ JAMA Otolaryngology-Head and Neck 
			Surgery, online June 5, 2014.
 
			[© 2014 Thomson Reuters. All rights 
				reserved.] Copyright 2014 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed. |